Observe Medical ASA: Notification of transaction by close associate to primary insider and disclosure of large shareholding

Oslo, 5 December 2024: Reference is made to the stock announcement published by Observe Medical ASA (the "Observe Medical") on 5 December 2024 regarding the final result of the subsequent offering and the partial conversion to shares of certain loans from Navamedic ASA ("Navamedic") to Observe Medical.

Navamedic currently holds 4,222,727 shares in Observe Medical, equal to approx. 1.72% of the current shares and votes in Observe Medical. Following the issuance and registration of the shares in both the subsequent offering and the shares to be issued to Navamedic in connection with the conversion, the Observe Medical's number of outstanding shares will be 288,876,175. The conversion will result in Navamedic increasing its shareholding from 4,222,727 shares to 45,109,765 shares, resulting in Navamedic holding approx. 15.62% of the new number of shares and votes in Observe Medical.

This information is subject to the disclosure requirements pursuant to article 19 of the EU Market Abuse Regulation and sections 4-2 and 5-12 of the Norwegian Securities Trading Act.